CFTR MODULATOR THERAPY FOR CYSTIC FIBROSIS CAUSED BY THE RARE C.3700A>G MUTATION

被引:0
|
作者
Phuan, P. [1 ]
Haggie, P. M. [1 ]
Tan, J. T. [1 ]
Rivera, A. [1 ]
Finkbeiner, W. [1 ]
Nielson, D. W. [1 ]
Thomas, M. [2 ]
Janahi, I. A. [3 ]
Verkman, A. S. [1 ]
机构
[1] UC San Francisco, Dept Med, San Francisco, CA USA
[2] Hamad Med Corp, Dept Chest, Doha, Ad Dawhah, Qatar
[3] Sidra Med & Res Ctr, Pediat Med, Doha, Ad Dawhah, Qatar
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
440
引用
收藏
页码:S210 / S210
页数:1
相关论文
共 50 条
  • [41] Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy
    Hisert, Katherine B.
    Birket, Susan E.
    Clancy, John Paul
    Downey, Damian G.
    Engelhardt, John F.
    Fajac, Isabelle
    Gray, Robert D.
    Lachowicz-Scroggins, Marrah E.
    Mayer-Hamblett, Nicole
    Thibodeau, Patrick
    Tuggle, Katherine L.
    Wainwright, Claire E.
    De Boeck, Kris
    LANCET RESPIRATORY MEDICINE, 2023, 11 (10): : 916 - 931
  • [42] CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis
    Westhoelter, Dirk
    Schumacher, Fabian
    Wulfinghoff, Nuria
    Sutharsan, Sivagurunathan
    Strassburg, Svenja
    Kleuser, Burkhard
    Horn, Peter A.
    Reuter, Sebastian
    Gulbins, Erich
    Taube, Christian
    Welsner, Matthias
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (04) : 713 - 720
  • [43] CFTR Modulator Therapy in an Adult Patient with Concurrent Cystic Fibrosis and Cerebral Palsy
    Bailey, J.
    Conrad, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [44] Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis
    Thakur, Shorya
    Ankita, Shubham
    Dash, Shubham
    Verma, Rupali
    Kaur, Charanjit
    Kumar, Rajesh
    Mazumder, Avijit
    Singh, Gurvinder
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (01) : 15 - 34
  • [45] Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis
    Shorya Thakur
    Shubham Ankita
    Rupali Dash
    Charanjit Verma
    Rajesh Kaur
    Avijit Kumar
    Gurvinder Mazumder
    Cell Biochemistry and Biophysics, 2024, 82 : 15 - 34
  • [46] Rare CFTR mutation 1525-1G>A in a Pakistani patient
    Wahab, A
    Al Thani, G
    Dawod, ST
    Kambouris, M
    Al Hamed, M
    JOURNAL OF TROPICAL PEDIATRICS, 2004, 50 (02) : 120 - 122
  • [47] Effects of triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy on glucose metabolism in cystic fibrosis patients
    Yesquen, Pamela
    Campos, Ariadna
    Mogas, Eduard
    Yeste, Diego
    Gartnet, Silvia
    Clemente, Maria
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 201 - 201
  • [48] Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy
    McDonald, Catherine M.
    Reid, Elizabeth K.
    Pohl, John F.
    Yuzyuk, Tatiana K.
    Padula, Laura M.
    Vavrina, Kay
    Altman, Kimberly
    NUTRITION IN CLINICAL PRACTICE, 2024, 39 : S57 - S77
  • [49] A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
    Ramsey, Bonnie W.
    Davies, Jane
    McElvaney, N. Gerard
    Tullis, Elizabeth
    Bell, Scott C.
    Drevinek, Pavel
    Griese, Matthias
    McKone, Edward F.
    Wainwright, Claire E.
    Konstan, Michael W.
    Moss, Richard
    Ratjen, Felix
    Sermet-Gaudelus, Isabelle
    Rowe, Steven M.
    Dong, Qunming
    Rodriguez, Sally
    Yen, Karl
    Ordonez, Claudia
    Elborn, J. Stuart
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18): : 1663 - 1672
  • [50] CYSTIC-FIBROSIS CAUSED BY HOMOZYGOSITY FOR THE CFTR GENE MUTATION 175INST
    SCHAEDEL, C
    SCHWARTZ, M
    KORNFALT, R
    HOLMBERG, L
    ACTA PAEDIATRICA, 1995, 84 (10) : 1199 - 1200